A medical resident is evaluating a newly published phase 3, randomized, controlled trial comparing a novel immunomodulator to standard therapy for the treatment of refractory plaque psoriasis. The resident is reviewing the methodology and results sections to present at the weekly journal club. The trial's patient enrollment and allocation are depicted in the accompanying CONSORT flow diagram. Match each excerpted statement from the publication to the corresponding methodological concept or principle it best represents.
- "Data from all randomized subjects were analyzed according to their initially assigned treatment group, regardless of whether they completed the full course of therapy."Intention-to-treat analysis
- "The upper bound of the 95% confidence interval for the difference in primary outcome rates between the novel immunomodulator and standard therapy did not cross the pre-defined 5% margin."Establishment of non-inferiority
- "A significantly larger proportion of subjects in the novel immunomodulator arm were lost to follow-up due to intolerable gastrointestinal side effects compared to the standard therapy arm."High risk of attrition bias
- "The study protocol strictly excluded patients with any history of psoriatic arthritis or metabolic syndrome, despite these conditions being highly prevalent in the target disease population."Limited external validity (generalizability)
Answer
Excerpt 1 matches with Intention-to-treat analysis. Excerpt 2 matches with Establishment of non-inferiority. Excerpt 3 matches with High risk of attrition bias. Excerpt 4 matches with Limited external validity (generalizability).
Proper interpretation of medical literature requires accurately identifying study design features and potential biases. Analyzing patients in their original randomized groups represents an intention-to-treat analysis, which preserves randomization benefits. When a trial's confidence interval for the treatment difference safely excludes the pre-specified margin, non-inferiority is established. Differential loss to follow-up creates attrition bias, threatening internal validity. Finally, strict exclusion criteria that eliminate typical, complex patients reduce the study's external validity (generalizability).
Step-by-Step Solution
Key Concept
Evaluation of clinical trial methodology, including intention-to-treat principles, non-inferiority design, internal validity threats, and external validity.
Estimated Time:1m 30s